KR830002801B1 - 고(高) 콜레스테롤혈증치료제, 모나콜린 k의 제조방법 - Google Patents

고(高) 콜레스테롤혈증치료제, 모나콜린 k의 제조방법 Download PDF

Info

Publication number
KR830002801B1
KR830002801B1 KR1019800000654A KR800000654A KR830002801B1 KR 830002801 B1 KR830002801 B1 KR 830002801B1 KR 1019800000654 A KR1019800000654 A KR 1019800000654A KR 800000654 A KR800000654 A KR 800000654A KR 830002801 B1 KR830002801 B1 KR 830002801B1
Authority
KR
South Korea
Prior art keywords
monacoline
cholesterol
days
monacholine
culturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019800000654A
Other languages
English (en)
Korean (ko)
Other versions
KR830002030A (ko
Inventor
아끼라 엔도
Original Assignee
상꾜가부시끼가이샤
가와무라 요시부미
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 상꾜가부시끼가이샤, 가와무라 요시부미 filed Critical 상꾜가부시끼가이샤
Publication of KR830002030A publication Critical patent/KR830002030A/ko
Application granted granted Critical
Publication of KR830002801B1 publication Critical patent/KR830002801B1/ko
Expired legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1019800000654A 1979-02-20 1980-02-19 고(高) 콜레스테롤혈증치료제, 모나콜린 k의 제조방법 Expired KR830002801B1 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP54017856A JPS5925599B2 (ja) 1979-02-20 1979-02-20 新生理活性物質モナコリンkおよびその製造法

Publications (2)

Publication Number Publication Date
KR830002030A KR830002030A (ko) 1983-05-21
KR830002801B1 true KR830002801B1 (ko) 1983-12-16

Family

ID=11955290

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019800000654A Expired KR830002801B1 (ko) 1979-02-20 1980-02-19 고(高) 콜레스테롤혈증치료제, 모나콜린 k의 제조방법

Country Status (27)

Country Link
JP (1) JPS5925599B2 (enrdf_load_stackoverflow)
KR (1) KR830002801B1 (enrdf_load_stackoverflow)
AT (1) AT373915B (enrdf_load_stackoverflow)
AU (1) AU532626B2 (enrdf_load_stackoverflow)
BE (1) BE881825A (enrdf_load_stackoverflow)
CA (1) CA1129794A (enrdf_load_stackoverflow)
CH (1) CH645890A5 (enrdf_load_stackoverflow)
DD (1) DD154494A5 (enrdf_load_stackoverflow)
DE (2) DE3051175C2 (enrdf_load_stackoverflow)
DK (2) DK149095C (enrdf_load_stackoverflow)
ES (1) ES8103171A1 (enrdf_load_stackoverflow)
FI (1) FI66427C (enrdf_load_stackoverflow)
FR (1) FR2449685B1 (enrdf_load_stackoverflow)
GB (1) GB2046737B (enrdf_load_stackoverflow)
HU (1) HU182069B (enrdf_load_stackoverflow)
IE (1) IE49743B1 (enrdf_load_stackoverflow)
IT (1) IT1175260B (enrdf_load_stackoverflow)
MX (1) MX6314E (enrdf_load_stackoverflow)
NL (1) NL191540C (enrdf_load_stackoverflow)
NO (1) NO153974C (enrdf_load_stackoverflow)
NZ (1) NZ192919A (enrdf_load_stackoverflow)
PH (1) PH15145A (enrdf_load_stackoverflow)
PL (1) PL124304B1 (enrdf_load_stackoverflow)
SE (1) SE453301B (enrdf_load_stackoverflow)
SG (1) SG6784G (enrdf_load_stackoverflow)
SU (2) SU1158048A3 (enrdf_load_stackoverflow)
ZA (1) ZA80962B (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110331151A (zh) * 2019-04-11 2019-10-15 北京工商大学 紫色红曲菌mokH基因过表达菌株的构建方法

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
JPS5621594A (en) * 1979-07-27 1981-02-28 Sankyo Co Ltd Mb-530b carboxylic acid metal salt and its preparation
AU548996B2 (en) * 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
PT72394B (en) * 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Mb−530a誘導体
JPS56142236A (en) 1980-04-08 1981-11-06 Sankyo Co Ltd Ml-236a and mb-530a derivative
DK149080C (da) * 1980-06-06 1986-07-28 Sankyo Co Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
JPS5835144A (ja) * 1981-08-27 1983-03-01 Sankyo Co Ltd Mb−530b誘導体およびその製造法
US4782084A (en) * 1987-06-29 1988-11-01 Merck & Co., Inc. HMG-COA reductase inhibitors
US4997848A (en) 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
CA2062023A1 (en) * 1992-02-10 1993-08-11 Jagroop S. Dahiya Novel fungal strains and use thereof in antibiotic production
WO1993017991A1 (en) * 1992-03-04 1993-09-16 Fujisawa Pharmaceutical Co., Ltd. TETRALIN DERIVATIVES AS HMG-CoA REDUCTASE INHIBITORS
ZA933359B (en) 1992-05-15 1993-12-08 Sankyo Co Octahydronaphthalene oxime derivatives for cholesterol biosynthesis inhibition, their preparation and use
HU210867B (en) * 1992-11-04 1995-10-30 Biogal Gyogyszergyar Method for extraction and purification of mevinolin from culture medium
US6812007B1 (en) * 1992-11-04 2004-11-02 Keri Vilmos Process for the isolation and purification of mevinolin
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
US5409820A (en) * 1993-08-06 1995-04-25 Apotex, Inc. Process for the production of lovastatin using Coniothyrium fuckelii
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
CZ300153B6 (cs) 1998-03-20 2009-02-25 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Metabolicky kontrolovaný proces fermentace pri výrobe lovastatinové hydroxykyseliny
AU3654301A (en) 2000-02-24 2001-09-03 Biogal Gyogyszergyar Method of purifying a fermentation broth
PL357533A1 (en) 2000-03-03 2004-07-26 Plus Chemicals, S.A. A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities
KR20010095780A (ko) * 2000-04-12 2001-11-07 나가오카 마사시 배아 홍국
IN192861B (enrdf_load_stackoverflow) 2000-06-30 2004-05-22 Ranbaxy Lab Ltd
AU2002235885A1 (en) 2001-02-09 2002-08-28 Unilever N.V. Process for the preparation of one or more statins by fermentation
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
KR20020093147A (ko) * 2002-05-30 2002-12-13 지니스생명공학 주식회사 성인병 예방 및 치료 보조제
KR100710500B1 (ko) 2005-05-18 2007-04-24 고려대학교 산학협력단 홍국균을 이용한 모나콜린 k 생산방법
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
SI2373609T1 (sl) 2008-12-19 2013-12-31 Krka, D.D., Novo Mesto Uporaba amfifilnih spojin za kontrolirano kristalizacijo statinov in intermediatov statinov
RO128803A0 (ro) 2012-10-12 2013-09-30 Ion Gigel Fulga Compoziţie pentru tratamentul sau prevenirea dislipidemiilor
CN111297938A (zh) * 2020-03-11 2020-06-19 北京康立生医药技术开发有限公司 一种辅助降血脂组合物中洛伐他汀的检测方法
JP2022135089A (ja) * 2021-03-04 2022-09-15 小林製薬株式会社 コレステロールの低減剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (enrdf_load_stackoverflow) 1974-06-07 1981-03-18
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b
AU535944B2 (en) * 1979-06-15 1984-04-12 Merck & Co., Inc. Hypocholestermic fermentation products from aspergillus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110331151A (zh) * 2019-04-11 2019-10-15 北京工商大学 紫色红曲菌mokH基因过表达菌株的构建方法

Also Published As

Publication number Publication date
DE3006216A1 (de) 1980-09-04
KR830002030A (ko) 1983-05-21
BE881825A (fr) 1980-08-20
PL222120A1 (enrdf_load_stackoverflow) 1980-10-20
ES488796A0 (es) 1981-02-16
DE3051175C2 (enrdf_load_stackoverflow) 1989-12-21
SU1158048A3 (ru) 1985-05-23
AU5567380A (en) 1980-08-28
FI800506A7 (fi) 1980-08-21
DK21889A (da) 1989-01-18
FR2449685B1 (fr) 1985-06-28
SE453301B (sv) 1988-01-25
PL124304B1 (en) 1983-01-31
DK73080A (da) 1980-08-21
NO153974B (no) 1986-03-17
NO153974C (no) 1986-06-25
DE3006216C2 (de) 1985-10-31
DK149095C (da) 1986-06-16
SE8001339L (sv) 1980-08-21
JPS55111790A (en) 1980-08-28
NL8001041A (nl) 1980-08-22
DK149095B (da) 1986-01-20
CA1129794A (en) 1982-08-17
CH645890A5 (de) 1984-10-31
DK21889D0 (da) 1989-01-18
GB2046737A (en) 1980-11-19
SG6784G (en) 1985-02-08
NL191540B (nl) 1995-05-01
SU969702A1 (ru) 1982-10-30
FI66427C (fi) 1984-10-10
FR2449685A1 (fr) 1980-09-19
MX6314E (es) 1985-04-01
IE800321L (en) 1980-08-20
GB2046737B (en) 1983-01-12
ATA92980A (de) 1983-07-15
PH15145A (en) 1982-08-24
NL191540C (nl) 1995-09-04
ZA80962B (en) 1981-03-25
IE49743B1 (en) 1985-12-11
IT1175260B (it) 1987-07-01
NZ192919A (en) 1984-07-06
DD154494A5 (de) 1982-03-24
ES8103171A1 (es) 1981-02-16
AT373915B (de) 1984-03-12
JPS5925599B2 (ja) 1984-06-19
HU182069B (en) 1983-12-28
NO800451L (no) 1980-08-21
AU532626B2 (en) 1983-10-06
FI66427B (fi) 1984-06-29
IT8067262A0 (it) 1980-02-20

Similar Documents

Publication Publication Date Title
KR830002801B1 (ko) 고(高) 콜레스테롤혈증치료제, 모나콜린 k의 제조방법
KR830002329B1 (ko) 모나콜린 k의 제조방법
JP3111470B2 (ja) 新規ポリペプチド化合物およびその製造法
EP1118617B1 (en) Compounds with an antioxidant acitivity, compositions useful as food integrators containing them and process for their preparation
WO1982000587A1 (en) New metabolites,processes for their production and their use
CN104497001B (zh) 莪术烯醇微生物转化衍生物及其制备方法和用途
JPH07145161A (ja) 新規セスキテルペン誘導体
US4753959A (en) Antibiotic lactone compound
WO1989009769A1 (en) Substance q-2819 and process for its preparation
JPH05271267A (ja) Fr901459物質、その製法及び用途
JP5163168B2 (ja) 新規fki−3864物質およびその製造方法
KR100427411B1 (ko) 아스퍼질러스 속 F70609(KCTC18055P)와 β-글루코시다제 저해제
JPH051777B2 (enrdf_load_stackoverflow)
JPH03232887A (ja) 新規物質bk97、その使用および製造
JPS62434A (ja) 新規化合物ss7313a及びその製造法並びにこれを含有する免疫調節剤
JPS6113798B2 (enrdf_load_stackoverflow)
JPH04243894A (ja) 新規q−6402化合物およびその製造法
JPH0585998A (ja) 新規化合物ca39‐aおよびca39‐b、ならびにその使用および製造
JPS61257921A (ja) 免疫抑制剤
JPH06135979A (ja) 新規物質nk374200、その製造法及びその用途
JPH0434522B2 (enrdf_load_stackoverflow)
JPH04224559A (ja) 血管新生阻害物質 fr−901448 およびfr−901449
JPH0632796A (ja) ベンズアントラセン誘導体、該誘導体を含有する抗腫瘍剤及びその製造方法
JPH02255655A (ja) 新規生理活性物質dc118
DK165990B (da) Fremgangsmaade til fremstilling af carboxylsyren af en cholesterolsynteseinhiberende forbindelse kaldet monacolin k eller salte deraf

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19800219

PG1501 Laying open of application
PG1605 Publication of application before grant of patent

Comment text: Decision on Publication of Application

Patent event code: PG16051S01I

PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 19840227

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 19840522

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 19840522

End annual number: 3

Start annual number: 1

PR1001 Payment of annual fee

Payment date: 19861114

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 19871123

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 19880210

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 19891120

Start annual number: 7

End annual number: 7

PR1001 Payment of annual fee

Payment date: 19901105

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 19911127

Start annual number: 9

End annual number: 9

PR1001 Payment of annual fee

Payment date: 19921127

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 19931112

Start annual number: 11

End annual number: 11

PR1001 Payment of annual fee

Payment date: 19941108

Start annual number: 12

End annual number: 12

PC1801 Expiration of term